Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery

prnewswire.com
JNJ PFE NVS

U.S. Pharmaceutical Market to Reach USD 965 Billion by 2035

globenewswire.com
ABT BIIB BMY GILD GSK LLY MRK NVS NVO PFE SNY

Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies

globenewswire.com
ABBV PFE

FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States

globenewswire.com
LLY NVO BMY AMGN AZN PFE ALT

HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare

prnewswire.com
PFE MRNA NVS LLY

ESR1 Mutated Metastatic Breast Cancer Market Research Report 2026: Epidemiological Analysis, Competitive Landscape, Regulatory Landscape, Pipeline Analysis, M&A, Regulatory Activities, Funding,

globenewswire.com
AZN BIO ROG PFE

Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma

globenewswire.com
NVS PFE EXEL MRK

Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

globenewswire.com
SNY ABBV LLY PFE

Form 8-K

sec.gov
PFE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

accessnewswire.com
VALN PFE